Glenmark Pharmaceuticals Limited is a research‐led, global pharmaceutical company, having a presence across branded, generics, and OTC segments; with a focus in the therapy areas of Respiratory, Dermatology and Oncology. The company has four research and development centres, ten world‐class manufacturing facilities spread across five continents, and operations in over eighty countries.
Glenmark is driven by a continuous commitment to create ‘A New Way for a New World’. Harnessing the potential of our core strengths of innovation, research, and scientific knowledge, we remain determined to consistently challenge established treatment paradigms. It allows us to identify and deliver promising solutions that make a considerable difference to the lives of patients in diverse geographies.
In the APAC region, we are dedicated to supporting doctors' practices and fostering a strong academic partnership, going beyond just providing medications. We are committed to being a trusted source of unbiased scientific information, helping doctors stay up-to-date and improve their knowledge.
We created Glenmark APAC Academy a uniquely designed, comprehensive online knowledge portal for healthcare professionals. Be part of this unique scientific forum and learn from a pool of eminent international and regional speakers .